Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
14
PharmaCompass offers a list of Ensartinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ensartinib manufacturer or Ensartinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ensartinib manufacturer or Ensartinib supplier.
A Ensartinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ensartinib, including repackagers and relabelers. The FDA regulates Ensartinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ensartinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ensartinib supplier is an individual or a company that provides Ensartinib active pharmaceutical ingredient (API) or Ensartinib finished formulations upon request. The Ensartinib suppliers may include Ensartinib API manufacturers, exporters, distributors and traders.
click here to find a list of Ensartinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ensartinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ensartinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ensartinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ensartinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ensartinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ensartinib suppliers with NDC on PharmaCompass.
Ensartinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ensartinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ensartinib GMP manufacturer or Ensartinib GMP API supplier for your needs.
A Ensartinib CoA (Certificate of Analysis) is a formal document that attests to Ensartinib's compliance with Ensartinib specifications and serves as a tool for batch-level quality control.
Ensartinib CoA mostly includes findings from lab analyses of a specific batch. For each Ensartinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ensartinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ensartinib EP), Ensartinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ensartinib USP).
